Obsidian Therapeutics
Obsidian Therapeutics seeks a Director or Senior Director of Manufacturing Science and Technology (MSAT) to lead end‑to‑end MSAT strategy for its autologous cell therapy program. The role will serve as the primary technical liaison with CDMOs, oversee process control, validation, and regulatory documentation, and drive data‑based improvements across manufacturing operations.
Headquarters
Cambridge, Massachusetts, United States
Obsidian Therapeutics is a clinical-stage biotechnology company using its proprietary cytoDRiVE® platform to engineer novel TIL (tumor-infiltrating lymphocyte) cell therapies. The platform leverages drug-responsive domains (DRDs) to regulate protein function using an FDA-approved small-molecule drug. The company's lead program, OBX-115 (amsoki-cel), is being evaluated in advanced melanoma in a Phase 1/2 clinical trial.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Obsidian Therapeutics.
36% above the average for this role
Director, MSAT, CMC & Process Validation
Artiva Biotherapeutics
Senior Process Engineer I
Beam Therapeutics
Senior Director of Manufacturing Science and Technology (MSAT)
AstraZeneca
Director, MSAT
Sana Biotechnology
Associate Director, Manufacturing Science and Technology
Apogee Therapeutics
Associate Scientific Director, Manufacturing Science & Technology (MSAT)
Neurocrine Biosciences